Desalting and Buffer Exchange Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product, by Technique and, by Application : Global Opportunity Analysis and Industry Forecast, 2023-2032

The Desalting and Buffer Exchange Market is expected to grow in upcoming years due to factors such as increase in demand for MAB’s (monoclonal antibodies) and rise in R&D expenditure by pharmaceutical and biotechnology companies.

Desalting and Buffer exchange is a process for the separation of bifurcation of soluble macromolecules from the smaller molecules. This process is known as desalting or replace buffer system. The system used for downstream application is called as buffer exchange system. The techniques are based on the principle of size exclusion and are used in laboratory for research. Advancements made in quality designs and material used in manufacturing of dialysis, desalting and difiltration devices has sped up with changes in scale, convenience and refinement, which are required by the modern research experiments.

COVID-19 scenario analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. Considering these factors, COVID -19 is expected to have significant impact on Desalting and Buffer Exchange Market.

Top Impacting factors:

• Factors such as rise in demand for monoclonal antibodies (MABs) and advancements in proteomic and genomic research is expected to boost the growth of desalting and buffer exchange market.
• Increase in R&D expenditure of biopharmaceutical companies on desalting and buffer exchange system is expected to fuel the growth of the market during the forecast period.
• Patent expiry of the blockbuster drugs and opportunities for growth in developing countries is expected to boost the market growth for desalting and buffer exchange.
• Restrain factors such as lack of knowledgeable individuals and skilled professionals, are affecting the growth of desalting and buffer exchange market up to some extent. 

New Product Launch / News:

• In January 2019, Biotage announced the acquisition of PhyNexus Inc. The acquisition aimed at providing Biotage with capabilities of providing enhanced solutions and products regarding lab-scale purification globally.
• In November 2017, Avantor Inc. announced the acquisition of VWR Corporation. VWR is a provider of various products and solutions related to laboratory. The acquisition made VWR a subsidiary of Avantor Inc. 

Key benefits of the report:

• This study presents the analytical depiction of the Desalting and Buffer Exchange Market along with the current trends and future estimations to determine the investments.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Desalting and Buffer Exchange Market share.
• The current market is quantitatively analyzed to highlight the Desalting and Buffer Exchange Market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
• The report provides a detailed Desalting and Buffer Exchange Market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Desalting and Buffer Exchange Market Report:

• What are the leading market players active in Desalting and Buffer Exchange Market?
• What the current trends will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the market?
• What are the projections for the future that would help in taking further strategic steps?
• What Segments and region will drive the market growth & why?

  Desalting and Buffer Exchange Market Report Highlights

Aspects	Details
By Product	Spin columns Filter plate Kits Cassettes and cartridges Membrane filters Other consumables and accessories
By Technique	Filtration Dialysis Ultrafiltration Chromatography Size exclusion chromatography Other chromatography techniques Precipitation
By Application	Bioprocess application Diagnostic application
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	Norgen Biotek Corp., GE Healthcare, Agilent Technologies, Thermo Fisher Scientific Inc., REPLIGEN CORPORATION, Merck KGaA, Bio-Rad Laboratories, Avantor Inc, General Electric Company, Sartorius